Seclaman E - Search Results

1

Molecular profiling of ADAM12 gene in breast cancers.

Nariţa D, Anghel A, Seclaman E, Ilina R, Cireap N, Ursoniu S. Nariţa D, et al. Among authors: seclaman e. Rom J Morphol Embryol. 2010;51(4):669-76. Rom J Morphol Embryol. 2010. PMID: 21103624 Free article.

2

Polymorphic variants of extracellular superoxide dismutase gene in a Romanian population with atheroma.

Samoila OC, Carter AM, Futers ST, Otiman G, Anghel A, Tamas L, Seclaman E. Samoila OC, et al. Among authors: seclaman e. Biochem Genet. 2008 Oct;46(9-10):634-43. doi: 10.1007/s10528-008-9177-3. Epub 2008 Aug 26. Biochem Genet. 2008. PMID: 18726685

3

Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia.

Anghel A, Mut-Vitcu B, Savu L, Marian C, Seclaman E, Iman R, Neghina AM, Dragulescu SI. Anghel A, et al. Among authors: seclaman e. Genomic Med. 2007;1(1-2):47-55. doi: 10.1007/s11568-007-9006-5. Epub 2007 May 25. Genomic Med. 2007. PMID: 18923928 Free PMC article.

4

VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature.

Cimpean AM, Seclaman E, Ceauşu R, Gaje P, Feflea S, Anghel A, Raica M, Ribatti D. Cimpean AM, et al. Among authors: seclaman e. Clin Exp Med. 2010 Sep;10(3):169-72. doi: 10.1007/s10238-009-0085-6. Epub 2009 Dec 24. Clin Exp Med. 2010. PMID: 20033752

5

Estrogen receptor alpha polymorphisms and the risk of malignancies.

Anghel A, Narita D, Seclaman E, Popovici E, Anghel M, Tamas L. Anghel A, et al. Among authors: seclaman e. Pathol Oncol Res. 2010 Dec;16(4):485-96. doi: 10.1007/s12253-010-9263-9. Epub 2010 Apr 11. Pathol Oncol Res. 2010. PMID: 20383761 Free article.

6

Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.

Anghel A, Raica M, Narita D, Seclaman E, Nicola T, Ursoniu S, Anghel M, Popovici E. Anghel A, et al. Among authors: seclaman e. Neoplasma. 2010;57(4):306-15. doi: 10.4149/neo_2010_04_306. Neoplasma. 2010. PMID: 20429621

7

ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.

Narita D, Seclaman E, Ilina R, Cireap N, Ursoniu S, Anghel A. Narita D, et al. Among authors: seclaman e. Pathol Oncol Res. 2011 Jun;17(2):375-85. doi: 10.1007/s12253-010-9336-9. Epub 2011 Jan 16. Pathol Oncol Res. 2011. PMID: 21240579 Free article.

8

Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.

Narita D, Seclaman E, Ursoniu S, Anghel A. Narita D, et al. Among authors: seclaman e. Acta Histochem. 2012 Feb;114(2):131-9. doi: 10.1016/j.acthis.2011.03.009. Epub 2011 Apr 17. Acta Histochem. 2012. PMID: 21501859

9

Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia.

Anghel A, Taranu G, Seclaman E, Rata A, Tamas L, Moldovan H, Ursoniu S, Samoila C, Ionac M, Popa-Wagner A. Anghel A, et al. Among authors: seclaman e. Curr Neurovasc Res. 2011 Aug 1;8(3):183-9. doi: 10.2174/156720211796558050. Curr Neurovasc Res. 2011. PMID: 21675956 Clinical Trial.

10

Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls.

Nariţa D, Seclaman E, Ursoniu S, Ilina R, Cireap N, Anghel A. Nariţa D, et al. Among authors: seclaman e. Rom J Morphol Embryol. 2011;52(4):1261-7. Rom J Morphol Embryol. 2011. PMID: 22203932 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters